In 2006, while Togo was elaborating its comprehensive multi-year plan for immunization (cMYP), its GAVI application for the introduction of the hepatitis B antigen into the Expanded Program on Immunization (EPI) was accepted, subject to clarifications. In this context, the Ministry of Health of Togo requested AMP’s technical assistance to develop its cMYP and to respond to GAVI's information requests. 

The specific objectives of AMP's support included: